Phytech raised €9.4M in a Series B round in Oct 2017. The company is based in Yad Mordechai, Israel. Investors in the round: Syngenta Ventures, Tencent Holdings. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
